Liver X receptor agonist T0901317 enhanced peroxisome proliferator-activated receptor-delta expression and fatty acid oxidation in rat skeletal muscle

Journal of Physiology and Pharmacology

Volumn 64, Issue 3, 2013, Pages

  Baranowski, M ^a   Blachnio Zabielska, A U ^a   Zabielski, P ^a   Harasim, E ^a   Harasiuk, D ^a   Chabowski, A ^a   Gorski, Jan ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Diacylglycerol acyltransferase; Fatty acid translocase CD36; Iver; Lipids; Low density lipoprotein; Nuclear receptors; Peroxisome proliferator activated receptor; Receptors; Sterol regulatory element binding protein 1c

Indexed keywords

CHOLESTEROL; DIACYLGLYCEROL ACYLTRANSFERASE; FATTY ACID; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; FOOD INTAKE; GASTROCNEMIUS MUSCLE; GENE TARGETING; LIPID BLOOD LEVEL; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTICHOLESTEREMIC AGENTS; DIACYLGLYCEROL O-ACYLTRANSFERASE; DOWN-REGULATION; FATTY ACIDS, NONESTERIFIED; HYDROCARBONS, FLUORINATED; HYPERTRIGLYCERIDEMIA; MALE; MUSCLE, SKELETAL; ORGAN SPECIFICITY; ORPHAN NUCLEAR RECEPTORS; OXIDATION-REDUCTION; PALMITIC ACID; PPAR DELTA; RANDOM ALLOCATION; RATS; RATS, WISTAR; RNA, MESSENGER; SULFONAMIDES; TRIGLYCERIDES; UP-REGULATION;

EID: 84881578700     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Apfel R, Benbrook D, Lernhardt E, Ortiz MA, Salbert G, Pfahl M. A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol Cell Biol 1994; 14: 7025-7035.
2. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 1995; 9: 1033-1045.
3. Bjorkhem I, Meaney S, Diczfalusy U. Oxysterols in human circulation: which role do they have? Curr Opin Lipidol 2002; 13: 247-253.
4. Schultz JR, Tu H, Luk A, et al. Role of LXRs in control of lipogenesis. Genes Dev 2000; 14: 2831-2838.
5. Peet DJ, Turley SD, Ma W, et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 1998; 93: 693-704.
6. Repa JJ, Turley SD, Lobaccaro JA, et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 2000; 289: 1524-1529.
7. Joseph SB, McKilligin E, Pei L, et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci USA 2002; 99: 7604-7609.
8. Terasaka N, Hiroshima A, Koieyama T, et al. T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice. FEBS Lett 2003; 536: 6-11.
9. Liang G, Yang J, Horton JD, Hammer RE, Goldstein JL, Brown MS. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J Biol Chem 2002; 277: 9520-9528.
10. Cao G, Liang Y, Broderick CL, et al. Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis. J Biol Chem 2003; 278: 1131-1136.
11. Laffitte BA, Chao LC, Li J, et al. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sci USA 2003; 100: 5419-5424.
12. Abdallah BM, Beck-Nielsen H, Gaster M. Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes. Eur J Clin Invest 2005; 35: 627-634.
13. Zhang Y, Mangelsdorf DJ. LuXuRies of lipid homeostasis: the unity of nuclear hormone receptors, transcription regulation, and cholesterol sensing. Mol Interv 2002; 2: 78-87.
14. Muscat GE, Wagner BL, Hou J, et al. Regulation of cholesterol homeostasis and lipid metabolism in skeletal muscle by liver X receptors. J Biol Chem 2002; 277: 40722-40728.
15. Roemen TH, van der Vusse GJ. Application of silica gel column chromatography in the assessment of non-esterified fatty acids and phosphoglycerides in myocardial tissue. J Chromatogr 1985; 344: 304-308.
16. Nawrocki A, Gorski J. Effect of plasma free fatty acid concentration on the content and composition of the free fatty acid fraction in rat skeletal muscles. Horm Metab Res 2004; 36: 601-606.
17. Baranowski M, Zabielski P, Blachnio A, Gorski J. Effect of exercise duration on ceramide metabolism in the rat heart. Acta Physiol (Oxf) 2008; 192: 519-529.
18. Harasim E, Chabowski A, Gorski J. Lack of downstream insulin-mimetic effects of visfatin/eNAMPT on glucose and fatty acid metabolism in skeletal muscles. Acta Physiol (Oxf) 2011; 202: 21-28.
19. Spangenburg EE, Brown DA, Johnson MS, Moore RL. Alterations in peroxisome proliferator-activated receptor mRNA expression in skeletal muscle after acute and repeated bouts of exercise. Mol Cell Biochem 2009; 332: 225-231.
20. Grefhorst A, van Dijk TH, Hammer A, et al. Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice. Am J Physiol Endocrinol Metab 2005; 289: E829-E838.
21. Cozzone D, Debard C, Dif N, et al. Activation of liver X receptors promotes lipid accumulation but does not alter insulin action in human skeletal muscle cells. Diabetologia 2006; 49: 990-999.
22. Kase ET, Thoresen GH, Westerlund S, Hojlund K, Rustan AC, Gaster M. Liver X receptor antagonist reduces lipid formation and increases glucose metabolism in myotubes from lean, obese and type 2 diabetic individuals. Diabetologia 2007; 50: 2171-2180.
23. Hessvik NP, Boekschoten MV, Baltzersen MA, et al. LXR[beta] is the dominant LXR subtype in skeletal muscle regulating lipogenesis and cholesterol efflux. Am J Physiol Endocrinol Metab 2010; 298: E602-E613.
24. Chu K, Miyazaki M, Man WC, Ntambi JM. Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation. Mol Cell Biol 2006; 26: 6786-6798.
25. Grefhorst A, Parks EJ. Reduced insulin-mediated inhibition of VLDL secretion upon pharmacological activation of the liver X receptor in mice. J Lipid Res 2009; 50: 1374-1383.
26. Baranowski M. Biological role of liver X receptors. J Physiol Pharmacol 2008; 59(Suppl 7): 31-55.
27. Joseph SB, Laffitte BA, Patel PH, et al. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem 2002; 277: 11019-11025.
28. Chisholm JW, Hong J, Mills SA, Lawn RM. The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse. J Lipid Res 2003; 44: 2039-2048.
29. Denechaud PD, Bossard P, Lobaccaro JM, et al. ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver. J Clin Invest 2008; 118: 956-964.
30. Baranowski M, Zabielski P, Blachnio-Zabielska AU, Harasiuk D, Gorski J. LXR activation prevents exhaustive exercise-induced hypoglycaemia and spares muscle glycogen but does not enhance running endurance in untrained rats. Acta Physiol (Oxf) 2011; 201: 373-379.
31. Hessvik NP, Bakke SS, Fredriksson K, et al. Metabolic switching of human myotubes is improved by n-3 fatty acids. J Lipid Res 2010; 51: 2090-2104.
32. Korach-Andre M, Parini P, Larsson L, Arner A, Steffensen KR, Gustafsson JA. Separate and overlapping metabolic functions of LXRalpha and LXRbeta in C57Bl/6 female mice. Am J Physiol Endocrinol Metab 2010; 298: E167-E178.
33. Augusto V, Padovani CR, Rocha Campos GE. Skeletal muscle fiber types in C57BL6J mice. Braz J Morphol Sci 2004; 21: 89-94.
34. Commerford SR, Vargas L, Dorfman SE, et al. Dissection of the insulin-sensitizing effect of liver X receptor ligands. Mol Endocrinol 2007; 21: 3002-3012.
35. Kase ET, Wensaas AJ, Aas V, et al. Skeletal muscle lipid accumulation in type 2 diabetes may involve the liver X receptor pathway. Diabetes 2005; 54: 1108-1115.
36. Kase ET, Andersen B, Nebb HI, Rustan AC, Thoresen GH. 22-Hydroxycholesterols regulate lipid metabolism differently than T0901317 in human myotubes. Biochim Biophys Acta 2006; 1761: 1515-1522.
37. Ehrenborg E, Krook A. Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor delta. Pharmacol Rev 2009; 61: 373-393.
38. Seo JB, Moon HM, Kim WS, et al. Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression. Mol Cell Biol 2004; 24: 3430-3444.
39. Colin S, Bourguignon E, Boullay AB, et al. Intestine-specific regulation of PPAR-alpha gene transcription by liver X receptors. Endocrinology 2008; 149: 5128-5135.
40. Korach-Andre M, Archer A, Gabbi C, et al. Liver X receptors regulate de novo lipogenesis in a tissue-specific manner in C57BL/6 female mice. Am J Physiol Endocrinol Metab 2011; 301: E210-E222.